<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126161">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02035774</url>
  </required_header>
  <id_info>
    <org_study_id>SSNB</org_study_id>
    <nct_id>NCT02035774</nct_id>
  </id_info>
  <brief_title>A Novel Selective Block of the Suprascapular Nerve</brief_title>
  <official_title>A Novel Selective Block of the Suprascapular Nerve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Tromso</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital of North Norway</source>
  <oversight_info>
    <authority>Norway: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who receive the lateral and sagittal infraclavicular block (LSIB) tend to supinate
      their hand  and forearm which may hamper optimal positioning for surgery of the dorsal side
      of the hand. The investigators think that this supination is caused by lateral rotation in
      the shoulder.  The main lateral rotator of the shoulder is the infraspinatus muscle, which
      is innervated by the suprascapular nerve (SSN).The investigators hypothesized that optimal
      positioning of the hand for surgery on the dorsal side of the hand may be achieved by
      performing a SSN block (SSNB) in addition to the LSIB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      According to the hypothesis the investigators will perform a double blind , placebo
      controlled study to answer the research question above.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Wrist angle</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigators will assess the wrist angle 30 minutes after the two blocks (LSIB + SSNB)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction score</measure>
    <time_frame>3 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigators will ask the surgeons about his/her satisfaction with the hand position during surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Ligament Injury</condition>
  <condition>Fracture</condition>
  <arm_group>
    <arm_group_label>LSIB +SSNB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive LSIB (31 ml ropivacaine 7.5 mg/ml)+ SSNB (4 ml Ropivacaine 5 mg/ml)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSIB + placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive LSIB (31 ml ropivacaine 7.5 mg/ml) + SSNB (4 ml saline)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LSIB + SSNB</intervention_name>
    <description>Patients will receive LSIB (31 ml ropivacaine 7.5 mg/ml)+ SSNB (4 ml Ropivacaine 5 mg/ml) or LSIB (31 ml ropivacaine 7.5 mg/ml)+ SSNB (4 ml placebo, saline)</description>
    <arm_group_label>LSIB +SSNB</arm_group_label>
    <arm_group_label>LSIB + placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with American Society of Anesthesiologists physical status (ASA) I- III

          -  age between 18 and 70 years

          -  body mass index between 20 and 36 kg/m2 scheduled for elective hand surgery.

        Exclusion Criteria:

        We will measure the angle between wrist and horizontal plane while the patient is supine
        and the extended arm 75° abducted.

          -  Patient who are not able to pronate the hand ≤15° before block performance, will be
             excluded from the study.

          -  Patients will also be excluded if they are pregnant, have contraindications to
             regional anesthesia, coagulation disorder, allergy to local anesthetics (LA),
             atrioventricular block, peripheral neuropathy or drug-treated diabetes.

          -  Patients using other anticoagulation drugs than acetylsalicylic acids or dipyridamol
             will be excluded.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars M Ytrebø, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of North Norway</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lars M Ytrebø, Professor</last_name>
    <phone>+4790788058</phone>
    <email>lars.marius.ytrebo@unn.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of North Norway</name>
      <address>
        <city>Tromsø</city>
        <state>Troms</state>
        <zip>9038</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva-Hanne Hansen</last_name>
      <phone>+4795259201</phone>
      <email>eva-hanne.hansen@unn.no</email>
    </contact>
    <investigator>
      <last_name>Sandra F Madsen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lars M Ytrebø, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Hackworth RJ. A new and simplified approach to target the suprascapular nerve with ultrasound. J Clin Anesth. 2013 Jun;25(4):347-8. doi: 10.1016/j.jclinane.2013.01.006. Epub 2013 May 1.</citation>
    <PMID>23643887</PMID>
  </reference>
  <reference>
    <citation>Siegenthaler A, Moriggl B, Mlekusch S, Schliessbach J, Haug M, Curatolo M, Eichenberger U. Ultrasound-guided suprascapular nerve block, description of a novel supraclavicular approach. Reg Anesth Pain Med. 2012 May-Jun;37(3):325-8. doi: 10.1097/AAP.0b013e3182409168.</citation>
    <PMID>22222688</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 13, 2014</lastchanged_date>
  <firstreceived_date>January 12, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of North Norway</investigator_affiliation>
    <investigator_full_name>Lars Marius Ytrebo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Brachial plexus block</keyword>
  <keyword>Suprascapular nerve block</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
